Aurobindo's combo AIDS drug gets tentative FDA OK

06/28/2013 | Business Standard (India)

The FDA gave tentative approval for Aurobindo Pharma's combination drug efavirenz+lamivudine+tenofovir to treat AIDS. The combination, which can be used by itself or with other antiretrovirals, is indicated for adult HIV-1 patients, as well as for adolescents older than 16 who weigh more than 88 pounds.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC